After decades of determined research, RNAi drugs have their day in the sun
A panel at Biotech Showcase last week provided an outlook for a new class of drugs that only entered the market two years ago, but was decades in the making.
For CAR-Ts to be successful, figuring out manufacturing is key
Efficacy, safety and reimbursement are all important things for CAR-T makers to figure out, but manufacturing is no less important.
presented by
The Top-Rated Orthopedic Surgery Centers in the Houston Area and Beyond
Discover Houston's best orthopedic surgery centers and what features — from personalized treatment plans to rehabilitation services — make these top providers stand out in their industry.
Cell, gene therapies demand creative payment models, but implementing them is a challenge, CEOs say
Performance- and time-based payment models - like the one bluebird bio has proposed for LentiGlobin - are especially harder to put into practice in the US than in Europe, some executives said at this week's JPM conference.
Industry execs forecast the year ahead for gene therapy at Biotech Showcase
Hospitals - especially in Europe - anticipate growing interest from international patients. But a wave of industry consolidation is debatable.
Five of Biotech Showcase’s most interesting startups
The startups highlighted stood out from the pack of some 300 life sciences companies presenting at this week's Biotech Showcase.